Accelero Ph2 randomized open label study of neoadjuvant zanidatamab + chemo in HER2+ breast

Phase II Clinical Trial

JZP598-208: A Phase 2 randomized multicenter open-label neoadjuvant study evaluating zanidatamab in combination with chemotherapy in participants with HER2-positive breast cancer.

Indication: Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer, Breast Cancer
Trial Number: 07102381
Trial Status: OPEN

Learn more about this clinical trial.

Participating Locations